V13G (p.Val13Gly) variant of PSEN2 (Presenilin-2)

V13G (p.Val13Gly) in PSEN2 (Presenilin-2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.38 / 1. The record also includes population frequency data and structural context.

V13G (p.Val13Gly) variant details